Sign up to save your podcasts
Or
Share Fed Expected to Cut Rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Fed Expected to Cut Rates
Plus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4.2
639639 ratings
Plus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ Minute Briefing
View all
WSJ Tech News Briefing
1,641 Listeners
WSJ What’s News
4,336 Listeners
WSJ Your Money Briefing
1,697 Listeners
Bloomberg Intelligence
404 Listeners
Bloomberg Businessweek
424 Listeners
WSJ Opinion: Potomac Watch
2,828 Listeners
Bold Names
1,442 Listeners
Wall Street Breakfast
1,037 Listeners
Thoughts on the Market
1,280 Listeners
The Journal.
5,977 Listeners
Wall Street Week
60 Listeners
Barron's Streetwise
1,556 Listeners
Barron's Live
193 Listeners
Bad Bets
1,321 Listeners
WSJ Opinion: Free Expression
605 Listeners
As We Work
151 Listeners
Bloomberg Daybreak: US Edition
75 Listeners
The Markets
78 Listeners
WSJ's Take On the Week
144 Listeners